Cite
HARVARD Citation
Clara, J. et al. (2022). High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells. Journal for immunotherapy of cancer. 10 (2), p. . [Online].